Thymulin

Thymulin is a nine amino acid hormone produced by the thymus, the gland that trains immune cells. It has one property that separates it from almost everything else on this site: it only works when bound to zinc, and without zinc it is biologically inert.

It was studied seriously in the 1970s and 1980s, mostly in France, and research largely moved on afterwards.

Why people are talking about it#

The zinc dependency, which is genuinely unusual. Most peptides are active as they are. This one is a two-part system, and that fact turns out to explain more about it than any of its marketing.

The immunology is the other draw. Thymic output falls steeply with age in a process called thymic involution, and a hormone from that gland is a natural candidate for anyone thinking about immune ageing.

What people take it for#

Immune support, mostly, and secondarily for inflammation and pain. It is sold alongside thymosin alpha-1 as part of a thymic peptide category.

Immune function#

The claim is a better-regulated immune system. The mechanism is genuine: thymulin is involved in T cell differentiation, and thymic output declines with age.

In practice that describes topping up a signal the body makes less of over time. Historical human work looked at this in immunodeficiency and in older adults, in small numbers, decades ago.

Inflammation and pain#

The claim is less pain and inflammation. Animal work has reported anti-inflammatory and analgesic effects, including in models of neuropathic pain.

Whether that transfers to a person has not been measured.

What the evidence shows#

The immunology is well described and appears in textbooks. Thymulin's role in T cell maturation and its zinc dependence are established science.

The clinical record is older and thinner. Small studies from the 1980s in immunodeficient patients and in the elderly reported changes in immune markers, with limited outcome data and methods that would look dated now. Nothing substantial has been published in recent decades.

The historical studies reported it as generally well tolerated, at the reporting standards of the time.

The zinc question#

Thymulin is only active as a zinc complex. The peptide without zinc bound to it does nothing, and this is not a footnote but the central fact of its pharmacology.

That makes it the one compound here where the chemistry of what arrives matters as much as the identity. Peptide identity and zinc-bound activity are two different things, and the first does not establish the second.

How it is taken#

Sold as a powder for reconstitution and subcutaneous injection. No modern dose has been established, so the figures in circulation trace back to the 1980s literature.

How it compares#

Against thymosin alpha-1#

Thymosin alpha-1 is the other thymic peptide in this category, and it has randomised trials, current clinical use and approvals in more than thirty countries. On evidence, the two are not close.

Against zinc on its own#

Worth asking, given the dependency. Zinc deficiency genuinely impairs immune function and zinc supplementation genuinely corrects it, with far more evidence than anything on this page.

Common questions#

Why does zinc matter so much?

Because the peptide is inert without it. The active molecule is the complex, not the peptide alone.

How old is the human evidence?

Mostly from the 1980s, and small.

Is it the same as thymosin alpha-1?

No. Both come from the thymus and they are different molecules with very different evidence bases.

What is thymic involution?

The steady shrinking of the thymus with age, which reduces the output of newly trained T cells.